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ABSTRACT 24 
Background: Brachial artery FMD is widely used as a non-invasive measure of endothelial 25 
function. Adherence to expert guidelines is believed to be of vital importance to obtain 26 
reproducible measurements. We conducted a systematic review of studies reporting on the 27 
reproducibility of the FMD in order to determine the relation between adherence to current expert 28 
guidelines for FMD measurement and its reproducibility. 29 
Methods: Medline-database was searched through July 2015 and 458 records were screened for 30 
FMD reproducibility studies reporting the mean difference and variance of repeated FMD 31 
measurements. An adherence score was assigned to each of the included studies based on 32 
reported adherence to published guidelines on the assessment of brachial artery FMD. A Typical 33 
Error Estimate (TEE) of the FMD was calculated for each included study. The relation between 34 
the FMD TEE and the adherence score was investigated by means of Pearson correlation 35 
coefficients and multiple linear regression analysis.  36 
Results: Twenty-seven studies involving 48 study groups and 1,537 subjects were included in the 37 
analyses. The adherence score ranged from 2.4 to 9.2 (out of a maximum of 10) and was strongly 38 
and inversely correlated with FMD TEE (adjusted R2=0.36, P<0.01). Use of automated edge-39 
detection software, continuous diameter measurement, true peak diameter for %FMD calculation, 40 
a stereostatic probe holder, and higher age emerged as factors associated with a lower FMD TEE. 41 
Conclusions: These data demonstrate that adherence to current expert consensus guidelines and 42 
applying contemporary techniques for measuring brachial artery FMD decreases its measurement 43 
error. 44 
Keywords: cardiovascular disease; atherosclerosis; endothelial function; reproducibility; 45 
methodology  46 
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INTRODUCTION  47 
The endothelium is a key regulator of vascular homeostasis and endothelial dysfunction is an 48 
early manifestation of atherosclerosis 1. Currently, the most widely used technique to study 49 
endothelial function in vivo is the flow-mediated dilation (FMD) of the brachial artery. This is a 50 
non-invasive, ultrasound-based method which correlates with endothelial function of the 51 
coronary arteries 2, 3 and independently predicts cardiovascular disease (CVD) 4, 5. The technique 52 
is attractive as a surrogate end-point, especially since changes in FMD can be detected across a 53 
relatively short timeframe 6. Despite its popularity, minor changes in the methodological 54 
approach may critically impact variability and decrease reproducibility of the FMD response 7-9. 55 
 56 
Previous expert consensus guidelines have made important contributions to standardize the 57 
technical approach and to set minimum standard requirements for FMD measurements 10, 11. 58 
However, not all studies on FMD apply these recommendations, or only in part. The impact of 59 
adherence to these guidelines on the reproducibility of FMD measurements is currently unclear, 60 
but may importantly contribute to the measurement error of the FMD technique Furthermore, 61 
little is known about the relative importance of the individual aspects of the expert-consensus 62 
guidelines to contribute to the reproducibility of the FMD. Better quantitative data on this matter 63 
can help reduce variation within and between studies, which will increase the statistical power of 64 
studies on FMD to detect changes and, subsequently, decrease chances for type II errors. 65 
 66 
In light of these considerations, we hypothesized that adherence to expert consensus guidelines is 67 
related to better reproducibility of FMD measurements 10, 11. Therefore, we performed a 68 
systematic search for published studies that reported data on reproducibility of FMD 69 
measurements, and investigated the relation between (full or partial) adherence to current expert 70 
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consensus guidelines and reproducibility of the FMD. Secondly, we explored which subject- and 71 
methodology-related factors were related to FMD reproducibility. 72 
 73 
METHODS 74 
Search Strategy 75 
The MEDLINE bibliographic database was searched (January 2000 through July 2015) for 76 
studies that assessed the reproducibility of the FMD using the following search terms: "flow 77 
mediated dilation", "flow mediated dilatation", "flow mediated vasodilation", "flow mediated 78 
vasodilatation", "endothelial function", "endothelial dysfunction", “FMD”, “FMV”, "brachial 79 
artery", “reproducibility”, “reliability”, “repeatability”, "coefficient of variation", “CV”, and 80 
“variance”. The search was limited to studies in human adults published in the English language. 81 
Additionally, we supplemented the search by hand-searching references of included studies and 82 
relevant reviews and meta-analyses on this topic. 83 
 84 
Selection of Studies  85 
Included studies were identified by means of a two-step selection process. During the first step, 86 
two reviewers (ACCMvM, AG) independently screened titles, abstracts and keywords of 87 
publications to identify potentially eligible studies. Studies were included if the mean difference 88 
and variance of repeated FMD measurements of the brachial artery were reported. During step 2 89 
of the selection, both reviewers examined the full text of these publications to gauge eligibility 90 
based on two additional inclusion criteria: FMD was determined through noninvasive ultrasound 91 
imaging, and a reactive hyperaemia protocol (with an ischemia duration of 4 to 5 minutes) was 92 
used to elicit the shear stress stimulus required for FMD. Thus, studies that adopted (ischemic) 93 
hand-grip exercise, passive movement and/or skin warming protocols to elicit (brachial) artery 94 
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dilation were not included in our analysis. In cases of discrepancy between the reviewers, 95 
eligibility was discussed along with a third reviewer (DHJT) until consensus was reached. 96 
 97 
Data extraction  98 
Study and subject characteristics: A standardized data collection sheet was used to extract 99 
general publication details (author, year of publication, country) and specific study- and subject 100 
characteristics: number of subjects, mean age (in years); CVD risk status of the study population 101 
(defined as presence of diagnosed CVD, hypertension or diabetes); baseline brachial artery 102 
diameter (in mm); % brachial artery FMD and its associated variance for each repeated 103 
measurement; and the mean absolute difference between repeated FMD measurements and its 104 
associated variance.  105 
 106 
Adherence to guidelines: We extracted information from the methods sections of the individual 107 
papers to assess the adherence to current expert-consensus guidelines. Based on recent guidelines 108 
11, we scored each individual study on the reporting of 19 different factors which were divided 109 
over 4 categories. The categories were related to: 1. Subject preparation (10 items), 2. Image 110 
acquisition (4 items), 3. Data analysis (3 items), and 4. Laboratory (2 items). Before performing 111 
the systematic literature search, values were assigned to each factor proportional to its perceived 112 
importance for valid assessment of the FMD. This was done through expert consensus discussion 113 
within the Working Group (AG, LG and DHJT) (see online data supplement). The “Adherence 114 
Score” that could be assigned to a study ranged from 0 to 10 points, depending on how many of 115 
the 19 different factors that were reported. In addition, we counted the number of previous studies 116 
on FMD published by the principal author of each study included in the systematic review. This 117 
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number served as a measure of the perceived experience in FMD measurements for each centre at 118 
the time of publication of the reproducibility data included here. 119 
 120 
Statistical analysis 121 
Reported measures of FMD reproducibility varied between studies. Many studies presented the 122 
coefficient of variation (CV) of repeated measurements, although this measure was calculated in 123 
a number of different ways, precluding direct comparisons. Measures of reproducibility included 124 
the technical error of the measurement (TEM), Pearson- and intraclass correlation coefficients 125 
(ICC), and limits of agreement. In order to make valid comparisons between studies, we defined 126 
as primary outcome measure the typical error of estimate (TEE) of FMD ,which is calculated as 127 
standard deviation of the paired differences/√2 12. 128 
 129 
Data are presented as mean ± SD or median (range) as appropriate for continuous variables and 130 
as frequencies for categorical variables. FMD TEE data were highly skewed (Shapiro-Wilk test, 131 
P<0.0001) and were log transformed prior to the analyses. Relations between log-FMD TEE and 132 
continuous variables were determined by Pearson correlation coefficients analysis. For 133 
categorical variables, the statistical significance of differences in FMD TEE between different 134 
levels were assessed by the Mann-Whitney U test. Significant correlates were entered in a 135 
multivariate linear regression analyses with backward elimination to identify independent 136 
predictors of FMD TEE. All analyses were conducted using JMP version 11.0 (SAS Institute 137 
Inc., Cary, NC, USA). 138 
 139 
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RESULTS  140 
Our systematic search identified 446 potentially relevant publications and an additional 12 were 141 
obtained through review of references of included studies, relevant reviews and meta-analyses. 142 
Twenty-seven studies 13-39 with 48 relevant study groups met our inclusion criteria and were 143 
included in our analysis (Figure 1). Characteristics of the included study groups are presented in 144 
Table 1. The 48 study groups comprised a total of 1,537 subjects (mean sample size 32; range, 8-145 
135) with a mean age of 41.5 years (range, 22-79 years). Eleven study groups included subjects 146 
with increased CVD risk, i.e. presence of diagnosed CVD, hypertension or diabetes. The other 147 
remaining 37 study groups consisted of healthy subjects. The time between repeated FMD 148 
measurements ranged from 25 minutes to 9 months. Mean baseline brachial diameter was 3.9 mm 149 
(range, 3.5 to 4.7 mm) and mean baseline FMD (i.e. this first of the two repeated measurements) 150 
was 7.1% (range, 1.8 to 19.9%). The FMD TEE ranged from 0.33 to 4.83% across study groups, 151 
with a mean value of 1.4%. The level of experience for each centre at the time of publication of 152 
the reproducibility study in question varied widely (number of previously published studies on 153 
FMD ranging from 0 to 71, median of 3). 154 
 155 
Methodology-related factors versus variation in FMD 156 
There was considerable variation in the methodological factors between studies. Adherence 157 
scores ranged from 2.4 to 9.2, with a mean of 5.3 (out of a maximum of 10). The adherence score 158 
was inversely correlated with log FMD TEE (adjusted R2=0.36, P<0.01, Figure 2).  159 
 160 
To explore the impact of the different aspects of the adherence score on the FMD TEE, we 161 
compared the FMD TEE between adherence (Yes vs No) to various methodological variables. 162 
Statistically significant differences in FMD TEE were found for use of the true peak diameter to 163 
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calculate %FMD, continuous brachial artery diameter measurement over the cardiac cycle, use of 164 
automated edge detection software and smoking cessation prior to measurements (Table 2). 165 
 166 
Subject-related factors versus variation in FMD 167 
For the remaining methodology related factors and subject characteristics, there were weak, but 168 
statistically significant correlations of log FMD TEE with age (adjusted R2= -0.18, P<0.01) and 169 
with baseline FMD (adjusted R2 0.11, P=0.013). In addition, FMD TEE was significantly smaller 170 
in the subgroup of studies that applied a stereostatic probe holder, and in studies performed by 171 
groups with more experience according to number of earlier publications on FMD. The %FMD 172 
TEE of studies above and below the median duration between repeated measurements (7 days) was 173 
not significantly different (Table 3), and there was no correlation between %FMD TEE and the 174 
time between repeated measurements (adjusted R2= -0.02, P<0.75). 175 
 176 
We constructed a stepwise multivariate regression model with log FMD TEE as the dependent 177 
variable and all factors that significantly influenced FMD TEE based on the individual analyses 178 
(adherence score, age, baseline FMD, probe holder and previous experience). The stepwise 179 
multivariate regression model predicted 51% of the variability in log FMD TEE. Adherence score 180 
(β= -0.16), age (β = -0.01) and probe holder (β = -0.19) remained as statistically significant 181 
(P<0.05) predictors in the model (Table 4).  182 
 183 
DISCUSSION 184 
Measurement of the FMD of the brachial artery has obtained in the recent years a well-185 
established predictive capacity for future CVD events. Despite this and its relatively 186 
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straightforward and non-invasive approach, the clinical use of the FMD is hampered by its 187 
sensitivity to variations in methodology.  188 
 189 
Our systematic analysis of previous studies that explored the FMD reproducibility provides us 190 
with a number of novel observations. First, we found considerable variation in the methodology 191 
applied to measure FMD and consequently, differences between studies in the adherence to 192 
current expert consensus guidelines. Secondly, these data show a robust inverse association 193 
between adherence to the guidelines and FMD reproducibility, with higher adherence to 194 
guidelines being related to smaller variation in FMD. Thirdly, we identified methodological 195 
factors that were associated with smaller variation in FMD. Specifically, the use of automated 196 
edge detection software, continuous measurement of brachial artery diameter over the cardiac 197 
cycle, calculating %FMD by means of the true peak diameter and use of a stereostatic probe 198 
holder were related to a better reproducibility. Taken together, our study provides strong 199 
scientific data that highlight the importance of rigorous application of standardized contemporary 200 
methodology to reduce measurement error of the FMD and, consequently, improve its use in 201 
(pre)clinical studies.  202 
 203 
To our knowledge, no previous study has explored the (relative) importance of adherence to 204 
expert consensus guidelines for measures of vascular health, including frequently used techniques 205 
like intima-media thickness, pulse wave velocity, and finger photoplethysmography. Taking all 206 
studies on the reproducibility of the FMD together, involving 1,537 subjects, we found a TEE of 207 
1.4% based on an average FMD of 7.1%. This indicates an overall good-to-acceptable 208 
reproducibility of the FMD. However, significant variation was observed between studies, with 209 
adherence to the expert consensus guidelines representing an important determinant of this 210 
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variation. Our data suggests that roughly 36% of the variation in FMD reproducibility can be 211 
explained through adherence to the guidelines alone. The presence of a linear relation between 212 
adherence to the guidelines and variation of the FMD suggests that measurement error would be 213 
further reduced with stricter adherence to the guidelines. Our data also indicate that even with full 214 
adherence to current expert consensus guidelines, some level of measurement error remains 215 
present. Nonetheless, a significant amount of variation in the FMD can be prevented by strong 216 
adherence to guidelines. 217 
 218 
Our analysis provides further insight into methodological factors that determine within-person 219 
error of the FMD measurement. For example, we found that taking the true peak artery diameter 220 
(rather than a fixed time point), continuous diameter measurement and automated edge-detection 221 
contribute to minimizing measurement error. The importance of these methodological factors 222 
have already been acknowledged in previous work. For example, Black et al. found that the peak 223 
diameter following cuff release differs between young and older subjects 7. Consequently, 224 
calculating the FMD% at an arbitrary time point (e.g. 60 seconds) may lead to misleading 225 
conclusions compared to a more sophistical approach in which diameter of the brachial artery is 226 
recorded continuously, allowing for the detection of the true peak dilation. Furthermore, previous 227 
work demonstrated that the adoption of edge-detection software to perform (observer-228 
independent) analysis leads to smaller variation compared to the application of manual calipers (a 229 
technique highly sensitive for measurement bias) 35, 40, 41. Whilst these studies highlight the 230 
importance of considering these factors for valid use of FMD, the present study highlights the 231 
importance of considering these factors to lower variation. Therefore, our study provides an 232 
additional rationale to perform continuous assessment of the diameter and the adoption of edge-233 
detection software when performing valid and reproducible assessments of the FMD. 234 
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 235 
Another important observation in our study was that previous experience of a laboratory with the 236 
FMD resulted in a smaller variation in FMD. A potential explanation for this finding is that 237 
experienced laboratories are more likely to demonstrate better adherence to the expert consensus 238 
guidelines. Indeed, when all factors were included in the final regression analysis (including 239 
adherence to the guidelines), previous experience of a laboratory with FMD did not emerge as an 240 
independent predictor of FMD reproducibility. Another factor that contributed to a smaller 241 
variation of the FMD was the use of a probe holder. The use of such devices is largely dependent 242 
on the personal preference of the laboratory and the effect on measurement reproducibility is a 243 
complex topic, since highly skilled operators with years of experience are able to conduct FMD 244 
measurements with exceptional reproducibility, regardless of the use of a probe holder 18. One 245 
may speculate that sonographers’ learning curves will likely differ depending on whether a probe 246 
holder is used or not and also depending on the design and construction of the probe holder itself. 247 
Therefore, despite the significant inverse association in our analysis, it remains difficult to 248 
ascertain whether use of a probe holder leads to a smaller variation in FMD per se. Further 249 
studies are needed to confirm the importance of using a probe holder to reduce variability of the 250 
FMD. 251 
 252 
Of the subject-related factors (age, diameter and baseline FMD), only age contributed 253 
independently to the variation in FMD. Notably, higher age of subjects was associated with a 254 
smaller variation in FMD. Older age is typically associated with a lower FMD 42, 43, which may 255 
contribute to a smaller (biological) variation and/or less ability to change in response to 256 
hemodynamic stimuli, consequently leading to a smaller measurement error. However, previous 257 
work suggests the presence of larger variability for measurements of vascular health in clinical 258 
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groups. For example, Craiem et al. found that subjects with CVD, despite comparable baseline 259 
FMD% values, demonstrate a larger coefficient of variation compared to healthy controls 21. At 260 
least, our data suggest that the reproducibility of the FMD may differ between (clinical) groups.  261 
 262 
Interestingly, the time duration between repeated measurements did not significantly affect FMD 263 
reproducibility in our analyses. This might seem counterintuitive as poorer reproducibility is 264 
expected as the time duration between repeated measurements increases. Indeed, a recent study 265 
specifically designed to determine FMD reproducibility over short (48 hours), medium (3 266 
months) and long (9 months) time frames did find poorer reproducibility at 9 months between 267 
repeated measurements 14. Reproducibility was comparable for the shorter time periods however, 268 
which is in agreement with a recent Italian multicenter study which found no differences in FMD 269 
reproducibility up to 30 days between measurements 15. It should be noted that there was a large 270 
heterogeneity in time between measurements in the included study groups, with the majority 271 
ranging between one and 15 days (n = 32) and some up to 30 (n=11), 90 (n = 4) and 270 days (n 272 
= 1). Excluding these last 16 studies from the analyses did not appreciably change our findings 273 
our findings however (data not shown). 274 
 275 
Limitations. An obvious limitation of our systematic review is that the degree of adherence to 276 
expert consensus guidelines was assessed from information as provided in the papers. If a 277 
methodological description omitted one or more of the 19 different scoring factors, no points 278 
were assigned for those factors. As a consequence some studies with sparse methodological 279 
descriptions received lower scores. Inconsequent reporting of methodological details might 280 
therefore have confounded our outcomes. It should also be acknowledged that our estimation of 281 
the experience of a laboratory with FMD measurements does not necessarily reflect the 282 
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experience of an individual sonographer. However, a laboratory more experienced in performing 283 
FMD measurements will generally require a level of skill and training for their sonographers that 284 
will meet at least the standard of their previous work. This highlights the importance of the level 285 
of experience in performing studies with FMD as an outcome variable. Another limitation is that 286 
our analysis on the relative importance of individual subject- and/or methodology-related factors 287 
could only be based on a between-study comparison of factors contributing to the reproducibility 288 
of the FMD. Various other factors may have influenced this analysis. Therefore, future studies 289 
are necessary to further explore the importance of (some of) the methodology-related factors, 290 
including the effects factors which we could not examine with the current dataset such as the 291 
observer/analyst, the time of cuff occlusion and changes in baseline brachial artery diameter. 292 
 293 
In conclusion, this systematic review shows that adherence to current expert consensus guidelines 294 
significantly reduces measurement error when assessing brachial artery FMD in humans. 295 
Moreover, when adopting the guidelines, we found that the use of contemporary techniques (i.e. 296 
continuous diameter recording, edge-detection and wall-tracking software and possibly also the 297 
use of a probe holder) is crucial to improve reproducibility of the FMD measurement. 298 
Considering these factors will importantly decrease measurement error of the FMD and, 299 
consequently, decrease chances for type II errors in studies that rely on FMD as their primary 300 
outcome parameter. In other words, ignoring current expert-consensus guidelines causes 301 
significant variability of the FMD and, consequently, may lead to spurious conclusions. This 302 
study delivers important insight that should be taken into account when developing future updates 303 
to expert-consensus guidelines. 304 
 305 
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FIGURE LEGENDS: 424 
Figure 1. Flow diagram of the study selection procedure. 425 
 426 
Figure 2. Linear correlation between the Typical Error of the Flow Mediated Dilation Estimate 427 
(FMD TEE) and adherence to expert guidelines (Adherence Score) in 27 studies (involving 48 428 
study groups) of FMD reproducibility. 429 
 430 
  431 
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TABLES: 432 
Table 1. General characteristics of the FMD reproducibility studies included in the systematic review. 433 












Kanahara 2014 13 Healthy 32 40 7.90 3.83 14 1.28 
Charakida 2013 14 
CVD, Diabetes 
67 61 4.10 4.55 2 0.94 
Charakida 2013 67 61 4.10 4.60 90 1.04 
Charakida 2013 67 61 4.10 4.65 270 1.47 
Ghiadoni 2012 15 
Healthy 
135 32 6.52 3.53 1 hour 0.83 
Ghiadoni 2012 135 32 6.52 3.55 30 1.15 
Onkelinx 2012 16 
CVD 
18 68 6.80 3.92 0.5 hour 0.94 
Onkelinx 2012 18 68 7.13 3.91 2 0.88 
Lima 2010 17 Healthy 31 25 13.17 3.57 2 2.91 
Thijssen 2009 18 Healthy 10 24 6.83 4.28 0.5 hour 0.89 
Donald 2008 (true peak 
diameter) 19 
Healthy 32 43 8.10 3.70 6 hours 0.79 
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Donald 2008 (true peak 
diameter) 
34 43 7.50 3.70 7 0.79 
Donald 2008 (true peak 
diameter) 
37 43 8.10 3.75 30 0.53 
Donald 2008 (true peak 
diameter) 
35 43 7.80 3.80 90 0.74 
Donald 2008 (60 sec) 32 43 7.30 3.70 6 hours 1.08 
Donald 2008 (60 sec) 34 43 6.70 3.70 7 0.95 
Donald 2008 (60 sec) 37 43 7.50 3.75 30 0.63 
Donald 2008 (60 sec) 35 43 7.10 3.80 90 0.87 
Simova 2008 20 
CVD, 
Hypertension 
40 62 6.05 3.84 0.25 hour 0.85 
Craiem 2007 21 
Healthy 
10 32 7.60 3.95 1 hour 0.80 
Craiem 2007 10 32 8.10 3.89 7 0.91 
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26 44 6.98 3.97 1 hour 1.34 
Craiem 2007 26 44 5.66 4.15 30 0.96 
Harris 2007 22 Healthy 9 57 7.80 4.11 2 1.32 
Meirelles 2007 23 
Healthy 
10 33 19.90 3.50 1.5 hours 2.70 
Meirelles 2007 13 33 16.50 3.55 3 2.50 
Donald 2006 24 Healthy 16 28 7.30 3.55 1 1.63 
Harris 2006 25 Healthy 16 23 9.88 3.74 2 hours 0.71 
Leeson 2006 26 Healthy 17 32 4.74 4.05 20 1.22 
Elsen 2005 27 Healthy 15 23 4.61 4.04 1 0.63 
Sejda 2005 28 
Healthy 
18 28 5.95 4.04 7 3.89 
Sejda 2005 18 28 4.23 4.15 7 1.63 
Stoner 2004 29 Healthy 9 23 10.20 3.90 2 3.26 
West 2004 30 
Diabetes 
18 55 5.57 4.01 7 0.81 
West 2004 18 55 5.57 4.01 14 1.07 
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Sidhu 2002 31 Healthy 12 36 5.38 3.94 20 0.37 
Sidhu 2002 CVD 12 62 1.80 4.29 20 0.33 
Beux 2001 32 
Healthy 
38 44 6.62 4.41 1 hour 1.97 
Beux 2001 38 44 4.32 4.41 1 hour 1.22 
De Roos 2001 33 Healthy 34 27 4.13 3.90 25 2.01 
Herrington 2001 34 
Healthy 
127 79 2.63 4.53 7 0.79 
Herrington 2001 30 45 7.87 4.35 7 1.46 
Woodman 2001 35 Healthy 24 55 6.60 4.06 7 0.71 
Lind 2000 36 
Healthy 
10 22 7.40 3.55 2 hours 2.19 
Lind 2000 10 22 7.40 3.55 21 2.82 
Preik 2000 37 Healthy 8 28 10.60 3.62 20 1.06 
Liang 1998 38 Healthy 30 44 10.80 3.84 18 2.01 
Hardie 1997 39 Healthy 19 36 3.00 3.78 90 4.83 
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Table 2. Relationship of individual components of the adherence score with FMD TEE 435 
Adherence Score Characteristic Median (IQR) %FMD TEE  
Subject preparation n No n Yes p 
Fasting state (>6h) 21 1.08 (0.83-2.10) 27 0.96 (0.80-1.47) 0.38 
No smoking/tobacco consumption prior to measurement (>6h) 22 0.89 (0.73-1.22) 26 1.30 (0.89-2.55) <0.01 
No habitual exercise prior to measurement (>48h) 31 1.22 (0.89-1.97) 17 0.87 (0.72-1.36) 0.07 
No food/beverages that contain alcohol and/or caffeine for >12 h 31 1.06 (0.79-1.97) 17 1.04 (0.82-1.40) 0.6 
No polyphenol-rich food/beverages (cocoa, tea, fruit juices) for >18 h 45 1.04 (0.79-1.63) 3 1.15 (0.83-2.91) 0.6 
No vitamins for at least 72h 44 1.05 (0.80-1.63) 4 0.99 (0.68-2.47) 0.8 
Vasoactive medications withheld/noted on the morning of the study 26 1.01 (0.79-1.98) 22 1.06 (0.84-1.51) 0.8 
Supine position; ≥15 min rest in a quiet, temperature controlled room 30 1.01 (0.80-1.72) 18 1.10 (0.82-1.60) 1.0 
Repeated measurements standardised to timing of the menstrual cycle  36 1.01 (0.79-1.89) 12 1.06 (0.84-1.59) 0.7 
Repeated measurements done in fixed time windows (same time of day) 7 1.22 (0.94-1.47) 41 0.96 (0.79-1.80) 0.5 
Image acquisition        
Diameter measurements recorded continuously over the cardiac cycle 35 1.22 (0.85-2.01) 13 0.88 (0.75-0.95) <0.01 
Diameter measurements obtained during end diastole only 15 0.89 (0.79-1.15) 33 1.22 (0.83-2.01) 0.06 
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Adherence Score Characteristic Median (IQR) %FMD TEE  
Simultaneous acquisition of pulse-wave Doppler velocity signal 




0.94 (0.79-1.21) 0.05 
Image analysis        
Analysis using automated edge detection and wall tracking software  13 2.19 (1.47-2.87) 35 0.91 (0.79-1.22) <0.01 
FMD calculation point (true peak diameter) 17 1.63 (0.94-2.76) 31 0.91 (0.79-1.28) <0.01 
Lab data        
Use of experienced sonographers reported  20 1.09 (0.73-2.38) 28 1.05 (0.82-1.47) 0.7 
Same sonographers paired to same subjects for repeated measurements 8 1.10 (0.86-1.44) 40 1.01 (0.79-1.89) 0.8 
 436 
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Age (years) -0.18 <0.01 
Baseline FMD (%)‡ 0.11 0.01 
Baseline diameter (mm) -0.02 0.15 
Number of subjects (n) -0.001 0.33 
Categorical variables Median (IQR) %FMD TTE 
 n No n Yes P-values 
CVD risk 37 1.15 (0.79-2.01) 11 0.94 (0.85-1.07) 0.31 
Distal occlusion cuff 
placement 
5 2.01 (0.91-2.6) 43 1.04 (0.79-1.47) 0.17 
Stereostatic probe holder 18 1.82 (1.02-2.85) 30 0.92 (0.73-1.22) <0.01 
Experienced centre* 23 1.32 (0.88-2.5) 25 0.91 (0.80-1.19) 0.01 
Time between repeated 
measurements above 
median† 
18 0.94 (0.81-1.72) 30 1.06 (0.71-1.61) 0.77 
‡ Baseline FMD refers to the first of the two repeated measurements 438 
*Centre experience was defined as the number of previous studies on FMD published by the 439 
principle author of each included study. The effect of centre experience was examined by 440 
comparing the %FMD TEE of studies below (No) and above (yes) the median number of 441 
previously published FMD studies. 442 
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†The effect of the time duration between studies was examined by comparing the %FMD TEE of 443 
studies below (no) and above (yes) the median duration of 7 days. 444 
445 
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Table 4. Relation of the adherence score, subject- and methodological factors with the 446 
reproducibility of the FMD measurement 447 
Stepwise Regression Analysis (model Adj R2=0.51) 
Variable β 95% CI P-value 
Adherence Score (unit) -0.16 -0.24; -0.07 <0.01 
Age (year) -0.01 -0.02; -0.001 0.03 
Stereostatic probe holder (yes) -0.19 -0.06; -0.33 <0.01 
The regression coefficient β represents the increase in the log FMD TEE per unit increase in each 448 
factor. Baseline FMD and Centre experience did not remain in the model 449 
  450 
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FIGURES: 451 
Figure 1: 452 
 453 
  454 
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Figure 2: 455 
 456 
